Purpose

The purpose of this study is to evaluate the utility of postoperative sitz baths in patient pain perception and recovery following surgical repair of prolapse. The SORE Study is a prospective, randomized controlled trial that aims to compare postoperative pain intensity one week after native tissue repair of pelvic organ prolapse for patients undergoing a sitz bath regimen versus usual care. Findings from this study may contribute to more robust, multimodal postoperative pain management plans if proven efficacious or, alternatively, reduce plastic medical waste and simplify postoperative pain plans if found to be ineffective.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Female ≥ 18 years of age at time of surgery - English or Spanish-speaking - Documentation of pelvic organ prolapse as evidenced by Stage 2, 3, or 4 prolapse on preoperative Pelvic Organ Prolapse Quantification system (POP-Q) examination - Surgery to be performed by a urogynecologist - Ambulatory or inpatient surgery acceptable

Exclusion Criteria

  • Mesh-augmented prolapse repair (robotic, laparoscopic, or open sacrocolpopexy or sacrohysteropexy, vaginal mesh) - Urogynecologic surgery without prolapse repair (i.e. midurethral sling, intravesicular botox, hysterectomy only) - Suspected genital herpes simplex virus (HSV), molluscum contagiosum virus (MCV), condyloma acuminata, or vulvar/vaginal skin and soft tissue infection at recruitment by patient report - Daily opioid use (short or long-acting) - Concurrent non-urogynecologic surgery (i.e. rectopexy, staging or debulking for malignancy) - Lack of access to operative report - Pregnant (as determined by positive urine pregnancy test on the day of surgery via standard testing or current pregnancy documented in the preoperative note) - Incarcerated - Unable to give consent/conserved - Unable to complete study intervention or assessment per investigators

Study Design

Phase
N/A
Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel Assignment
Intervention Model Description
The study population will consist of adult patients undergoing native tissue surgical repair of pelvic organ prolapse at a Yale-affiliated hospital.
Primary Purpose
Supportive Care
Masking
None (Open Label)

Arm Groups

ArmDescriptionAssigned Intervention
Experimental
Sitz baths plus usual care
Warm water sitz baths plus usual care. 7-day nightly regimen of warm water soaks without additives.
  • Device: Sitz Bath
    Warm water sitz bath, 7 nights, 10 minutes each
No Intervention
Usual care
Care as usual

Recruiting Locations

Bridgeport Hospital
Bridgeport 5282804, Connecticut 4831725 06610

Greenwich Hospital
Greenwich 4835395, Connecticut 4831725 06830

Yale-New Haven Hospital
New Haven 4839366, Connecticut 4831725 06520

Lawrence + Memorial Hospital
New London 4839416, Connecticut 4831725 06320

More Details

NCT ID
NCT07215780
Status
Recruiting
Sponsor
Yale University

Study Contact

Melissa Markowitz, MD
203-909-5267
melissa.markowitz@yale.edu

Detailed Description

The primary objective of the SORE study is to compare postoperative pain intensity one week after native tissue repair of pelvic organ prolapse for patients undergoing a sitz bath regimen versus usual care. The secondary objectives of this study are to evaluate patient satisfaction with pain management after native tissue prolapse repair (and specifically posterior repair and/or perineorrhaphy), patient-reported opioid requirements, healthcare utilization, postoperative pain plan adherence, and incisional healing and complications between those undergoing a sitz bath regimen versus usual care.

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.